Atlas Trials

Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment

Clinical trial NCT03309202 · COMPLETED

Trial details

NCT number
NCT03309202
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2017-12-19
Primary completion
2018-06-26
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.